CYTOKINETICS, INCORPORATED Noncash or Part Noncash Acquisition, Fixed Assets Acquired
CYTOKINETICS, INCORPORATED (CYTK) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $170.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2015-03-06
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2014-12-31 was -$30.00K, a 136.14% decline year-over-year.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2014-09-30 was -$4.00K.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2014-06-30 was $297.00K, a 2021.43% increase year-over-year.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2014-03-31 was -$93.00K, a 180.87% decline year-over-year.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for fiscal 2014 was $170.00K, a 11.92% decline from fiscal 2013.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for fiscal 2013 was $193.00K, a 66.38% increase from fiscal 2012.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for fiscal 2012 was $116.00K, a 792.31% increase from fiscal 2011.
- CYTOKINETICS, INCORPORATED noncash or part noncash acquisition, fixed assets acquired for fiscal 2011 was $13.00K, a 90.78% decline from fiscal 2010.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 185 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 188 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 191 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 194 month |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | -$34.00K derived: sum of 2 quarters · filed 2015-03-06 | $263.00K derived: sum of 3 quarters · filed 2015-03-06 | $170.00K 10-K · filed 2015-03-06 | ||||
| 2014-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $293.00K derived: sum of 2 quarters · filed 2014-11-06 | $200.00K 10-Q · filed 2014-11-06 | $283.00K derived: sum of 4 quarters · filed 2015-03-06 | ||||
| 2014-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $204.00K 10-Q · filed 2014-08-07 | $287.00K derived: sum of 3 quarters · filed 2015-03-06 | $268.00K derived: sum of 4 quarters · filed 2015-03-06 | ||||
| 2014-03-31 | -$93.00K 10-Q · filed 2014-05-07 | -$10.00K derived: sum of 2 quarters · filed 2015-03-06 | -$29.00K derived: sum of 3 quarters · filed 2015-03-06 | -$15.00K derived: sum of 4 quarters · filed 2015-03-06 | ||||
| 2013-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $64.00K derived: sum of 2 quarters · filed 2015-03-06 | $78.00K derived: sum of 3 quarters · filed 2015-03-06 | $193.00K 10-K · filed 2015-03-06 | ||||
| 2013-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$5.00K derived: sum of 2 quarters · filed 2014-11-06 | $110.00K 10-Q · filed 2014-11-06 | $110.00K 10-Q · filed 2013-11-06 | ||||
| 2013-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $129.00K 10-Q · filed 2014-08-07 | $129.00K 10-Q · filed 2013-08-07 | |||||
| 2013-03-31 | $115.00K 10-Q · filed 2014-05-07 | $115.00K 10-Q · filed 2013-05-08 | ||||||
| 2012-12-31 | $116.00K 10-K · filed 2015-03-06 | $116.00K 10-K · filed 2013-03-15 | ||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$26.00K derived: sum of 2 quarters · filed 2014-03-07 | $13.00K 10-K · filed 2014-03-07 | |||||
| 2011-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $13.00K 10-Q · filed 2012-11-07 | ||||||
| 2011-06-30 | $39.00K 10-Q · filed 2012-08-06 | |||||||
| 2010-12-31 | $141.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |